Cancer cell-intrinsic STING is associated with CD8 + T-cell infiltration and might serve as a potential immunotherapeutic target in hepatocellular carcinoma

被引:0
作者
Y. Zhang
Q. Zhai
X. Feng
D. Chen
Y. Lu
J. Hu
H. Xie
L. Zhou
J. Wu
S. Zheng
机构
[1] Zhejiang University,Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine
[2] NHC Key Laboratory of Combined Multi-Organ Transplantation,Key Laboratory of the Diagnosis and Treatment of Organ Transplantation
[3] CAMS,Department of Anesthesiology & Center for Brain Science, The First Affiliated Hospital
[4] Key Laboratory of Organ Transplantation,undefined
[5] Xi’an Jiaotong University,undefined
[6] Zhejiang Provincial Research Center for Diagnosis and Treatment of Heapatobiliary Diseases,undefined
来源
Clinical and Translational Oncology | 2021年 / 23卷
关键词
STING; Hepatocellular carcinoma; CD8 + T cell; Immunotherapy; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1314 / 1324
页数:10
相关论文
共 50 条
[21]   Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction [J].
Kunimasa, Kei ;
Isei, Taiki ;
Nakamura, Harumi ;
Kimura, Madoka ;
Inoue, Takako ;
Tamiya, Motohiro ;
Nishino, Kazumi ;
Kumagai, Toru ;
Nakatsuka, Shin-ichi ;
Endo, Hiroko ;
Inoue, Masahiro ;
Imamura, Fumio .
INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) :1138-1142
[22]   Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction [J].
Kei Kunimasa ;
Taiki Isei ;
Harumi Nakamura ;
Madoka Kimura ;
Takako Inoue ;
Motohiro Tamiya ;
Kazumi Nishino ;
Toru Kumagai ;
Shin-ichi Nakatsuka ;
Hiroko Endo ;
Masahiro Inoue ;
Fumio Imamura .
Investigational New Drugs, 2018, 36 :1138-1142
[23]   Multi-omics Perspective on the Tumor Microenvironment based on PD-L1 and CD8 T-Cell Infiltration in Urothelial Cancer [J].
Chen, Siteng ;
Zhang, Ning ;
Shao, Jialiang ;
Wang, Tao ;
Wang, Xiang .
JOURNAL OF CANCER, 2019, 10 (03) :697-707
[24]   Central and Effector Memory CD4 and CD8 T-Cell Responses to Tumor-Associated Antigens [J].
Caserta, Stefano ;
Borger, Jessica Geraldine ;
Zamoyska, Rose .
CRITICAL REVIEWS IN IMMUNOLOGY, 2012, 32 (02) :97-126
[25]   Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC [J].
Gabrielson, Andrew ;
Wu, Yunan ;
Wang, Hongkun ;
Jiang, Jiji ;
Kallakury, Bhaskar ;
Gatalica, Zoran ;
Reddy, Sandeep ;
Kleiner, David ;
Fishbein, Thomas ;
Johnson, Lynt ;
Island, Eddie ;
Satoskar, Rohit ;
Banovac, Filip ;
Jha, Reena ;
Kachhela, Jaydeep ;
Feng, Perry ;
Zhang, Tiger ;
Tesfaye, Anteneh ;
Prins, Petra ;
Loffredo, Christopher ;
Marshall, John ;
Weiner, Louis ;
Atkins, Michael ;
He, Aiwu Ruth .
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (05) :419-430
[26]   Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration [J].
Gan, Lunbiao ;
Lu, Tong ;
Lu, Yu ;
Song, Hongtao ;
Zhang, Jiayu ;
Zhang, Keying ;
Lu, Shiqi ;
Wu, Xinjie ;
Nie, Fengze ;
Di, Sijia ;
Han, Donghui ;
Yang, Fa ;
Qin, Weijun ;
Wen, Weihong .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (09)
[27]   Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma [J].
Liang, Junnan ;
Liao, Jingyu ;
Chang, Ruizhi ;
Jia, Wenlong ;
Li, Ganxun ;
Chen, Zeyu ;
Wu, Hang ;
Zhu, Chang ;
Wen, Jingyuan ;
Huang, Qibo ;
Gao, Han ;
Gui, Zichen ;
Xu, Weiqi ;
Liang, Huifang ;
Liu, Qiumeng ;
Xu, Dafeng ;
Li, Zifu ;
Xia, Limin ;
Chen, Xiaoping ;
Huang, Zhao ;
Zhang, Wanguang ;
Ding, Zeyang ;
Zhang, Bixiang .
SCIENCE IMMUNOLOGY, 2025, 10 (108) :eado3485
[28]   A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma [J].
Banglun Pan ;
Yue Luo ;
Dongjie Ye ;
Jiacheng Qiu ;
Xiaoxia Zhang ;
Xiaoxuan Wu ;
Yuxin Yao ;
Xiaoqian Wang ;
Nanhong Tang .
Cancer Immunology, Immunotherapy, 2023, 72 :4103-4119
[29]   A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma [J].
Pan, Banglun ;
Luo, Yue ;
Ye, Dongjie ;
Qiu, Jiacheng ;
Zhang, Xiaoxia ;
Wu, Xiaoxuan ;
Yao, Yuxin ;
Wang, Xiaoqian ;
Tang, Nanhong .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) :4103-4119
[30]   Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma [J].
Zongqiang Hu ;
Gang Chen ;
Yingpeng Zhao ;
Hongqiang Gao ;
Laibang Li ;
Yanfeng Yin ;
Jie Jiang ;
Li Wang ;
Yuanyi Mang ;
Yang Gao ;
Shengning Zhang ;
Jianghua Ran ;
Li Li .
Molecular Cancer, 22 (1)